Skip to Content

Picato Approval History

FDA Approved: Yes (First approved January 23, 2012)
Brand name: Picato
Generic name: ingenol mebutate
Dosage form: Topical Gel
Company: Leo Pharma
Treatment for: Keratosis

Picato (ingenol mebutate) is an inducer of cell death indicated for the topical treatment of actinic keratosis.

Development History and FDA Approval Process for Picato

DateArticle
Jan 25, 2012Approval FDA Approves Picato (ingenol mebutate) Gel, the First and Only Topical Actinic Keratosis (AK) Therapy With 2 or 3 Consecutive Days of Once-Daily Dosing

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide